Nanotherapy Has Potential for Treatment of Type 1 Diabetes: Study

Washington [US], January 22 (ANI): A recent study led by a team of researchers at Northwestern University has discovered a technique to help make immunomodulation more effective. The method used nanocarriers to re-engineer the commonly used immunosuppressant rapamycin.
Their paper was published in the journal ‘Nature Nanotechnology’.
The Northwestern team was led by Evan Scott, the Kay Davis Professor and an associate pro

Article: bignewsnetwork.com